No Data
No Data
12 Health Care Stocks Moving In Wednesday's After-Market Session
BrainStorm Issues 2024 Letter to Shareholders
Analysts Offer Insights on Healthcare Companies: Opus Genetics (IRD) and Brainstorm Cell Therapeutics (BCLI)
BrainStorm Cell Therapeutics to Host Investor Call and Provide a Corporate Update
BrainStorm Strengthens Exosome Patent Portfolio: Receives Notice of Allowance for U.S. Patent Covering Its Platform Technology
BrainStorm Cell Therapeutics to Host KOL Webinar on Current Developments in the Treatment of Amyotrophic Lateral Sclerosis (ALS) on December 11, 2024